Evaluación psicológica del abuso de fármacos opioides

  1. Carballo Crespo, José Luis
  2. Coloma Carmona, Ainhoa
  3. Mrozowicz Gaudyn, Dana
  4. Vidal Arenas, Verónica
  5. Hofstadt Román, Carlos J. van der
  6. Rodríguez Marín, Jesús
Revista:
Papeles del psicólogo

ISSN: 0214-7823,  1886-1415

Año de publicación: 2016

Título del ejemplar: Avances en evaluación psicológica

Volumen: 37

Número: 1

Páginas: 45-51

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Papeles del psicólogo

Resumen

El incremento de la preinscripción de fármacos analgésicos opioides se ha asociado a un aumento de las tasas de abuso y las consecuencias negativas asociadas a su uso inadecuado. Diversos organismos sanitarios internacionales recomiendan la realización de una evaluación global y multidisciplinar del paciente durante todo el proceso terapéutico con opiáceos, con el fin de identificar un posible abuso. Ante la ausencia de quías específicas en el ámbito sanitario español, el objetivo de este artículo ha sido presentar una propuesta de evaluación psicológica, en base a los principales instrumentos de evaluación, disponibles actualmente para evaluar el abuso de opioides. Se establecen pautas para el proceso de evaluación en función de las variables psicológicas que puedan predecir y mantener dicho abuso, clasificando todo ello en función del momento del proceso terapéutico en el que los pacientes se encuentren, Aunque existen instrumentos con buenas propiedades psicométricas, son necesarias futuras investigaciones para la adaptación, traducción y validación de éstos a población española. Al mismo tiempo son necesarios futuros estudios que profundicen en estrategias de prevención e intervención para reducir la probabilidad de abuso en pacientes tratados con fármacos opioides.

Referencias bibliográficas

  • Atluri, S., Sudarshan, G., & Manchikanti, L. (2014). Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician, 17(2), E119-128.
  • Badia, X., Muriel, C., Gracia, A., Nunez-Olarte, J. M., Perulero, N., Galvez, R., Carulla, J., et al. (2003). [Validation of the Spanish ver sion of the Brief Pain Inventory in patients with oncological pain]. Medicina Clínica, 120(2), 52–59.
  • Barry, D. T., Irwin, K. S., Jones, E. S., Becker, W. C., Tetrault, J. M., Sullivan, L. E., Hansen, H., et al. (2010). Opioids, Chronic Pain, and Addiction in Primary Care. The Journal of Pain : Official Journal of the American Pain Society, 11(12), 1442-1450.
  • Butler, S. F., Budman, S. H., Fernandez, K. C., Fanciullo, G. J., & Jamison, R. N. (2009). Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). Journal of Addiction Medicine, 3(2), 66-73.
  • Butler, S. F., Budman, S. H., Fernandez, K. C., Houle, B., Benoit, C., Katz, N., & Jamison, R. N. (2007). Development and Validation of the Current Opioid Misuse Measure. Pain, 130(1-2), 144-156.
  • Butler, S. F., Fernandez, K., Benoit, C., Budman, S. H., & Jamison, R. N. (2008). Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). The Journal of Pain : Official Journal of the American Pain Society, 9(4), 360.
  • Centers for Disease Control and Prevention. (2011). Vital signs: overdoses of prescription opioid pain relievers---United States, 1999-2008. MMWR. Morbidity and Mortality Weekly Report, 60(43), 1487-1492.
  • Centers for Disease Control and Prevention. (2013). Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010. MMWR. Morbidity and Mortality Weekly Report, 62(26), 537-542.
  • Chang, Y.-P., & Compton, P. (2013). Management of chronic pain with chronic opioid therapy in patients with substance use disorders. Addiction Science & Clinical Practice, 8(1), 21.
  • Chou, R. (2009). 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice? Polskie Archiwum Medycyny Wewn�trznej, 119(7-8), 469-477.
  • Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., et al. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain : Official Journal of the American Pain Society, 10(2), 113-130.
  • Chou, R., Fanciullo, G. J., Fine, P. G., Miaskowski, C., Passik, S. D., & Portenoy, R. K. (2009). Opioids for Chronic Noncancer Pain: Prediction and Identification of Aberrant Drug-Related Behaviors: A Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. The Journal of Pain, 10(2), 131-146.e5.
  • Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129-138.
  • Dhalla, I. A., Mamdani, M. M., Sivilotti, M. L. A., Kopp, A., Qureshi, O., & Juurlink, D. N. (2009). Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Canadian Medical Association Journal, 181(12), 891-896.
  • Edlund, M. J., Martin, B. C., Fan, M.-Y., Braden, J. B., Devries, A., & Sullivan, M. D. (2010). An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study. Journal of Pain and Symptom Management, 40(2), 279-289.
  • Garcia del Pozo, J., Carvajal, A., Viloria, J. M., Velasco, A., & Garcia del Pozo, V. (2008). Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. European Journal of Clinical Pharmacology, 64(4), 411-415.
  • Gomes, T., Juurlink, D. N., Dhalla, I. A., Mailis-Gagnon, A., Paterson, J. M., & Mamdani, M. M. (2011). Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Medicine, 5(1), e13-e22.
  • Knisely, J. S., Wunsch, M. J., Cropsey, K. L., & Campbell, E. D. (2008). Prescription Opioid Misuse Index: A brief questionnaire to assess misuse. Journal of Substance Abuse Treatment, 35(4), 380-386.
  • Leong, M., Murnion, B., & Haber, P. S. (2009). Examination of opioid prescribing in Australia from 1992 to 2007. Internal Medicine Journal, 39(10), 676-681.
  • Liebschutz, J., Beers, D., & Lange, A. (2014). Managing Chronic Pain in Patients With Opioid Dependence. Current Treatment Options in Psychiatry, 1(2), 204-223.
  • Llach, X. B., Cleeland, C. S., Muriel, C., Gracia, A., Perulero, N., Carulla, J., Olarte, J. M. N., et al. (2003). Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica. Medicina Clínica, 120(2), 52-59.
  • Manchikanti, L., Abdi, S., Atluri, S., Balog, C. C., Benyamin, R. M., Boswell, M. V., Brown, K. R., et al. (2012). American Society of In terventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2–guidance. Pain Physician, 15(3 Suppl), S67–116.
  • Matteliano, D., St Marie, B. J., Oliver, J., & Coggins, C. (2012). Adherence Monitoring with Chronic Opioid Therapy for Persistent Pain: A Biopsychosocial-Spiritual Approach to Mitigate Risk. Pain Management Nursing. Recuperado junio 22, 2014, a partir de http://www.sciencedirect.com/science/article/pii/S15249042120
  • Morasco, B. J., Duckart, J. P., & Dobscha, S. K. (2011). Adherence to Clinical Guidelines for Opioid Therapy for Chronic Pain in Patients with Substance Use Disorder. Journal of General Internal Medicine,26(9), 965-971.
  • Morgan, L., Weaver, M., Sayeed, Z., & Orr, R. (2013). The use of prescription monitoring programs to reduce opioid diversion and improve patient safety. Journal of Pain & Palliative Care Pharmacotherapy, 27(1), 4-9.
  • National Institute on Drug Abuse. (2012). Los medicamentos de prescripción: Abuso y Adicción. Washington, DC: NIH. OEDT. (2011). Informe 2011: Situación y tendencias de los problemas de drogas en España. Madrid: Ministerio de Sanidad, Política Social e Igualdad.
  • Passik, S. D. (2009). Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions. Mayo Clinic Proceedings, 84(7), 593601.
  • Passik, S. D., Kirsh, K. L., & Casper, D. (2008). Addiction-Related Assessment Tools and Pain Management: Instruments for Screening, Treatment Planning, and Monitoring Compliance. Pain Medicine, 9, S145-S166.
  • Passik, S. D., Kirsh, K. L., Whitcomb, L., Portenoy, R. K., Katz, N. P., Kleinman, L., Dodd, S. L., et al. (2004). A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clinical Therapeutics, 26(4), 552-561.
  • Quintana, J. M., Padierna, A., Esteban, C., Arostegui, I., Bilbao, A., & Ruiz, I. (2003). Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 107(3), 216-221.
  • Rubio, G., Bermejo, J., Caballero, M. C., & Santo-Domingo, J. (1998). AUDIT. Revista Clínica Española, 198(1), 11–14.
  • SAMHSA. (2013a). Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings (NSDUH Series H46, HHS Publication No. (SMA) 13-4789.). Rockville, MD: Substances Abuse and Mental Health Services Administration.
  • SAMHSA. (2013b). Drug Abuse Warning Network, 2011: National Estimates of Drug – Related Emergency Department Visits (HHS Publication No. (SMA) 13-4760,DAWN Series D-39.). Rockville, MD: Substances Abuse and Mental Health Services Administration. Recuperado abril 23, 2014, a partir de http://jflahiff.wordpress.com/2013/07/19/drug-abuse-warning-network-2011-natio nal-estimates-of-drug-related-emergency-department-visits/
  • SAMHSA. (2013c). Treatment Episode Data Set (TEDS): 2001-2011. State Admissions to Substance Abuse Treatment Services. (BHSIS Series S-68, HHS Publication No. (SMA) 14-4832.). Rockville, MD: Substances Abuse and Mental Health Services Administration.
  • Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (Abingdon, England), 88(6), 791-804.
  • Secades Villa, R., Rodríguez García, E., Valderrey Barbero, J., Fernández Hermida, J. R., Vallejo Seco, G., & Jiménez García, J. M. (2003). El consumo de psicofármacos en pacientes que acuden a Atención Primaria en el Principado de Asturias (España). Psicothema, 15 (4), 650-655.
  • Sehgal, N., Manchikanti, L., & Smith, H. S. (2012). Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician, 15(3), ES67–ES92.
  • Substance Abuse and Mental Health Services Administration. (2012). Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders. SAMHSA/CSAT Treatment Improvement Protocols. Rockville (MD): Substance Abuse and Mental Health Services Administration (US).
  • Sullivan, M. D., Edlund, M. J., Fan, M.-Y., DeVries, A., Braden, J. B., & Martin, B. C. (2010). Risks for Possible and Probable Opioid Misuse Among Recipients of Chronic Opioid Therapy in Commercial and Medic aid Insurance Plans: the TROUP Study. Pain, 150(2), 332339.
  • Sullivan, M. D., & Howe, C. Q. (2013). Opioid therapy for chronic pain in the United States: Promises and perils. Pain, 154(0 1), S94– 100.
  • Thorson, D., Biewen, P., Bonte, B., Epstein, H., Haake, B., Hansen, C., Hooten, M., et al. (2014). Acute Pain Assessment and Opioid Prescribing Protocol. Recuperado julio 20, 2014, a partir de https://www.icsi.org/_asset/dyp5wm/Opioids.pdf
  • Turk, D. C., Swanson, K. S., & Gatchel, R. J. (2008). Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. The Clinical Journal of Pain, 24(6), 497-508.
  • Upshur, C. C., Luckmann, R. S., & Savageau, J. A. (2006). Primary Care Provider Concerns about Management of Chronic Pain in Community Clinic Populations. Journal of General Internal Medicine, 21(6), 652-655.
  • Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine (Malden, Mass.), 6(6), 432-442.
  • Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361-370.
Fuente de los datos: Dialnet